Adiana

Marlborough, United States Founded: 1997 • Age: 29 yrs Acquired By Cytyc
Transcervical sterilization systems for permanent birth control are developed.

About Adiana

Adiana is a Healthcare company based in Marlborough (United States) founded in 1997, and was acquired by Cytyc in February 2007. Transcervical sterilization systems for permanent birth control are developed. Adiana has raised $23 million across 1 funding round from investors including Boston Scientific, Orbimed and Abingworth. Its focus areas include Life Sciences, Women Health, Medical Devices and Therapy. Its competitors include Daré Bioscience, Femasys and Hera Health Solutions; 2 of its 3 listed competitors have raised funding.

Company details

The company was founded in 1997 in Marlborough, United States, focusing on medical devices in womens health. A transcervical sterilization system for permanent birth control was developed, incorporating a radiofrequency generator, disposable delivery catheter, and implantable polymer matrix per fallopian tube. FDA approval was received in 2009. Acquisition by Cytyc, now part of Hologic, occurred in February 2007.

  • Headquarters Marlborough, United States
  • Stage Acquired
  • Sectors
    Healthcare
  • Website adiana.com
  • Social X
  • Acquired by Cytyc (Feb 2007)
Key Metrics
  • Total Equity Funding
    $23M (USD)

    in 1 rounds

  • Latest Funding Round
    $23M (USD), Series D

    Aug 2005

  • Investors
  • Acquired by
    Cytyc

    (Feb 2007)

Funding Insights of Adiana

Adiana has successfully raised a total of $23M through 1 strategic funding round. The most recent funding activity was a Series D round of $23 million completed in August 2005. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $23M
  • Total Rounds 1
  • Last Round Series D — $23M
  • First Round $23M

    (Aug 2005)

  • Investors Count 9

All 1 funding rounds of Adiana with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Aug 2005$23MSeries D–Tullis Health Investors
Valuation history

10 investors in total: 10 institutional.

Investors in Adiana

Adiana has secured backing from 10 investors, including venture fund and institutional investors. Prominent investors backing the company include Boston Scientific, Orbimed and Abingworth.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Healthcare investments are made by Tullis Health Investors.
tullisfunds.comPalm Beach Gardens, United States
Investments are made by OrbiMed in global healthcare innovations across biopharmaceuticals and related fields.
1989orbimed.comNew York, United States
Early stage venture capital firm investing in the US
alloyventures.comPalo Alto, United States
Investments are made in life sciences firms across all stages.
delphiventures.comMenlo Park, United States
Early stage venture capital firm investing in US
1973abingworth.comLondon, United Kingdom
Life Sciences focused VC firm that does early stage investments in the US
forwardventures.comSan Diego, United States
Growth stage VC fund investing in the US, Europe and Canada
oakwoodmedical.comSt. Louis, United States
Tech and Life Sciences focused corporate VC firm investing in the US
kpventures.comOakland, United States
Wide range of medical devices
1979bostonscientific.comMarlborough, United States
Diagnostic medical devices for cancer and women's health are developed.
1987cytyc.comMarlborough, United States
Premium access

Investor details for Adiana

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of Adiana

3 dated milestones of Adiana across 10 years, from founding to its latest funding, stage changes and deals.

  1. Founded Adiana is founded.
  2. Funding First funding round of $23.0M.
  3. Exit Acquired by Cytyc.

Competitors of Adiana

Adiana has 3 listed competitors in our database, 2 of them funded. They include Daré Bioscience, Femasys and Hera Health Solutions.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
darebioscience.com2005San Diego, United States30
Non-hormonal pharmaceutical products for female contraceptives are developed.
femasys.com2004Atlanta, United States$69.22M25
Medical devices for women's healthcare are developed and provided.
herahealthsolutions.com2017Dallas, United States$227,358
Contraceptive arm implants are developed for female birth control.
Premium access

Detailed competitors of Adiana

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Adiana

Websites that share an audience with Adiana (adiana.com).

Similar websites

Websites whose visitors overlap most with Adiana. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
essure.com
essure.com
100%
#5,771,977–

Top companies in Women's Health & Fertility

3 companies that operate in the same segment as Adiana (Women's Health & Fertility) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Developer of cell-free DNA testing for oncology, women’s health, and organ health
2004Redwood City, California, United StatesUSD 152.1 MUSD 2.31 B4,430
Therapeutics for women's healthcare are developed and offered.
1997Princeton, New Jersey, United StatesUSD 123.06 MUSD 19.59 M
Provider of cell-free cancer liquid biopsy test
2015San Francisco, California, United StatesUSD 388.62 M861
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Adiana

Premium access

Complete news archive for Adiana

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Adiana

Adiana was founded in 1997 and raised its 1st funding round 8 years after it was founded.

Adiana is headquartered in Marlborough, United States. It is registered at Marlborough, Massachusetts, United States.

Adiana is a funded company, having raised a total of $23M across 1 funding round to date. The company's 1st funding round was a Series D of $23M, raised on Aug 2005.

The company was founded in 1997 in Marlborough, United States, focusing on medical devices in womens health. A transcervical sterilization system for permanent birth control was developed, incorporating a radiofrequency generator, disposable delivery catheter, and implantable polymer matrix per fallopian tube. FDA approval was received in 2009. Acquisition by Cytyc, now part of Hologic, occurred in February 2007.

Adiana's top competitors include Daré Bioscience, Femasys and Hera Health Solutions.

Adiana has 10 investors. Key investors include Boston Scientific, Orbimed, Abingworth, Cytyc, and Tullis Health Investors.

Yes. Adiana was acquired by Cytyc in February 2007.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available